215 related articles for article (PubMed ID: 30877756)
1. Epigallocatechin-3-gallate inhibits angiotensin II-induced cardiomyocyte hypertrophy via regulating Hippo signaling pathway in H9c2 rat cardiomyocytes.
Ma Y; Hu Y; Wu J; Wen J; Li S; Zhang L; Zhang J; Li Y; Li J
Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):422-430. PubMed ID: 30877756
[TBL] [Abstract][Full Text] [Related]
2. Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways.
Li HL; Huang Y; Zhang CN; Liu G; Wei YS; Wang AB; Liu YQ; Hui RT; Wei C; Williams GM; Liu DP; Liang CC
Free Radic Biol Med; 2006 May; 40(10):1756-75. PubMed ID: 16767845
[TBL] [Abstract][Full Text] [Related]
3. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
[TBL] [Abstract][Full Text] [Related]
4. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
5. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms regarding potassium bromate‑induced cardiac hypertrophy without apoptosis in H9c2 cells.
Kuo SC; Li Y; Cheng YZ; Lee WJ; Cheng JT; Cheng KC
Mol Med Rep; 2018 Nov; 18(5):4700-4708. PubMed ID: 30221729
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E
Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
[TBL] [Abstract][Full Text] [Related]
10. Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
Chen Y; Yuan J; Jiang G; Zhu J; Zou Y; Lv Q
Mol Med Rep; 2017 Oct; 16(4):4545-4552. PubMed ID: 28849081
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin gallate, the major component of polyphenols in green tea, inhibits telomere attrition mediated cardiomyocyte apoptosis in cardiac hypertrophy.
Sheng R; Gu ZL; Xie ML
Int J Cardiol; 2013 Jan; 162(3):199-209. PubMed ID: 22000973
[TBL] [Abstract][Full Text] [Related]
12. Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1.
Jiang Q; Lu M; Li J; Zhu Z
Cardiovasc Ther; 2021; 2021():5554569. PubMed ID: 34257705
[TBL] [Abstract][Full Text] [Related]
13. [Over-expression of BDNF inhibits angiotensin II-induced apoptosis of cardiomyocytes in SD rats].
Cao J; Wu Y; Liu G; Li Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar; 34(3):218-224. PubMed ID: 29773102
[TBL] [Abstract][Full Text] [Related]
14. [Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
Wang NN; Wang J; Tan HL; Wang YG; Gao Y; Ma ZC
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(8):1642-1647. PubMed ID: 31090329
[TBL] [Abstract][Full Text] [Related]
15. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats.
Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
Acta Pharmacol Sin; 2007 Feb; 28(2):191-201. PubMed ID: 17241521
[TBL] [Abstract][Full Text] [Related]
16. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
[TBL] [Abstract][Full Text] [Related]
17. Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
Kang BY; Khan JA; Ryu S; Shekhar R; Seung KB; Mehta JL
J Cardiovasc Pharmacol; 2010 Apr; 55(4):417-24. PubMed ID: 20422739
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II.
Zheng Y; Song HJ; Kim CH; Kim HS; Kim EG; Sachinidis A; Ahn HY
J Cardiovasc Pharmacol; 2004 Feb; 43(2):200-8. PubMed ID: 14716206
[TBL] [Abstract][Full Text] [Related]
19. Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity.
Yan L; Zhang JD; Wang B; Lv YJ; Jiang H; Liu GL; Qiao Y; Ren M; Guo XF
PLoS One; 2013; 8(9):e72548. PubMed ID: 24039778
[TBL] [Abstract][Full Text] [Related]
20. Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models.
Ozakca I
J Cardiovasc Pharmacol; 2019 Mar; 73(3):155-164. PubMed ID: 30601193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
